FIT Biotech is an innovative medical biotechnology company engaged in the development and commercialisation of its proprietary Gene Transport Unit (GTU®) technology and GTU® product applications in DNA vaccination as well as in immuno- and gene therapies.

FIT Biotech's most important R&D activity since the start of its operations has been the development of an HIV vaccine.